MYRIAD GENETICS INC — Director's Dealing 2015

Oct 27, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-10-23

Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-23	Common Stock	M	940.0	$16.53	Acquired	71677	Direct
2015-10-23	Common Stock	S	940.0	$41.8	Disposed	70737	Direct
2015-10-26	Common Stock	M	11491.0	$16.53	Acquired	82228	Direct
2015-10-26	Common Stock	S	11491.0	$41.8	Disposed	70737	Direct
2015-10-27	Common Stock	M	7298.0	$16.53	Acquired	78035	Direct
2015-10-27	Common Stock	S	7298.0	$41.8	Disposed	70737	Direct
2015-10-27	Common Stock	M	5038.0	$22.93	Acquired	75775	Direct
2015-10-27	Common Stock	S	5038.0	$41.8	Disposed	70737	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-23	Non-Qualified Stock Option (right to buy)	$16.53	M	940.0	Disposed	2020-09-15	Common Stock (940)	Direct
2015-10-26	Non-Qualified Stock Option (right to buy)	$16.53	M	11491.0	Disposed	2020-09-15	Common Stock (11491)	Direct
2015-10-27	Non-Qualified Stock Option (right to buy)	$16.53	M	7298.0	Disposed	2020-09-15	Common Stock (7298)	Direct
2015-10-27	Non-Qualified Stock Option (right to buy)	$22.93	M	5038.0	Disposed	2018-09-10	Common Stock (5038)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.